{"organizations": [], "uuid": "68523e45fd80b4f519d87880dbed40297f1df38d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://images.wsj.net/im-10990/social", "site_section": "https://www.wsj.com/news/business", "section_title": "Business &amp; Finance News - Wall Street Journal", "url": "https://www.wsj.com/articles/no-fda-seal-of-approval-for-these-big-biotechs-1526577113", "country": "US", "domain_rank": 387, "title": "No FDA Seal of Approval for These Big Biotechs", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.065, "site_type": "news", "published": "2018-05-17T21:11:00.000+03:00", "replies_count": 0, "uuid": "68523e45fd80b4f519d87880dbed40297f1df38d"}, "author": "Charley Grant", "url": "https://www.wsj.com/articles/no-fda-seal-of-approval-for-these-big-biotechs-1526577113", "ord_in_thread": 0, "title": "No FDA Seal of Approval for These Big Biotechs", "locations": [], "entities": {"persons": [{"name": "dru", "sentiment": "neutral"}], "locations": [], "organizations": [{"name": "fda", "sentiment": "none"}, {"name": "g administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Investors got another reminder that profits at large biotech companies are fragile.\nThe Food and Drug Administration published a list of companies Thursday that it says employ “gaming tactics” to delay generic competition for branded drugs.\nThe FDA’s list of 52 drugs includes blockbuster treatments for serious diseases. High-profile examples... To Read the Full Story Subscribe Sign In", "external_links": [], "published": "2018-05-17T21:11:00.000+03:00", "crawled": "2018-05-17T22:52:39.020+03:00", "highlightTitle": ""}